Emergency Medicine Reports - August 21, 2005

Target Audience:

This activity is intended for the emergency physician.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Ralph J. Riviello, MD, FACEP
Assistant Professor and Clinical Research Director
Department of Emergency Medicine
Jefferson Medical College
Philadelphia, PA;
Medical Director
Sexual Assault Treatment Center
Thomas Jefferson University Hospital
Philadelphia, PA

Peer Reviewers
Allison Harvey, MD, FACEP, FAAEM
Clinical Faculty
Palmetto Richland Memorial Hospital Residency Program
SANE Medical Director Palmetto Health
Columbia, SC

Meta Carroll, MD, FAAP, FACEP
Pediatric Emergency Physician Northwest Acute Care Specialists
Portland, OR, and Vancouver, WA

Gideon Bosker, MD
Special Clinical Projects and Medical
Education Resources
Assistant Clinical Professor
Section of Emergency Services
Yale University School of Medicine


  • Evaluating and Treating Sexual Assault in the Emergency Department, Part I: Initial ED Care, Physical Exam, and Evidence Collection


  • Quickly recognize or increase index of suspicion for specific conditions
  • Understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Perform necessary diagnostic studies correctly
  • Take a meaningful patient history that will reveal the most important details about the particular medical problem discussed
  • Apply state-of-the-art therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • Have an understanding of the differential diagnosis of the entity discussed
  • Understand both likely and rare complications that may occur
  • Provide patients with any necessary discharge instructions

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Ralph J. Riviello, MD, FACEP (author) reports receiving research funding from Ortho-McNeil, Scios, and Merck Phamaceuticals.

Allison Harvey, MD, FACEP, FAAEM and Mita Carroll, MD, FAAP, FACEP (peer reviewers) report no relationships with companies related to the field of study covered by this CME program.

Gideon Bosker, MD, FACEP (editor) has been compensated for speaking engagements and/or editorial services related to production of peer-reviewed Clinical Consensus Reports under the auspices of unrestricted educational grants for Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, Roche Pharmaceuticals, Bayer, Novartis, Forest Pharmaceuticals, and Schering Plough Corporation.

Dr. Bosker also acknowledges that he has received royalties, commissions, and other compensation relating to the sale of textbooks, reprints of articles, and/or other electronic or print materials to the following pharmaceutical companies: Pfizer, Sanofi-Aventis, Bayer, Roche, Forest Laboratories, and Novartis. He is a minor stockholder in Pfizer. Any other stock ownership which he may have in other pharmaceutical companies is managed in blinded fashion by an independent consultant without Dr. Bosker's input or consultation.

Copyright 2005 AHC Media. All rights reserved.